Examining The History Of Neurocore

Neurocore is one of the leading authorities on applied neurosciences but its history dates all the way back to the late 18th century. As it happens, Luigi Galvani and Alessandro Volta are now considered to be the founding fathers of modern electrophysiology and bioelectric theory but, back in the 1790’s, they were just two scientists struggling to understand the basics of neurofeedback. They attempted to do so by attaching frog legs to an iron fence whenever there was a lightning storm and observe the effects. They found that these particular legs would contract whenever a flash of lightning streaked across the sky. They hypothesized that this was due to dissimilarities in the electrical currents. See more information about Neurocore at Linkedin.com.

However, the two scientists found themselves unable to definitively prove their theory until well into the 1800’s. Their findings and research would eventually lead to the development of what is now known as the electroencephalogram otherwise known as the EEG which is now used by Neurocore. It functions by attaching these small metals disks known as electrodes to a person’s scalp which enables them to monitor the electrical impulses within the cerebellum. Hans Berger became one of the first scientists to observe the effects of the EEG on a patient and he documented his findings in his new paper fittingly entitled “About the Human Electroencephalogram”.

Visit: https://www.facebook.com/NeurocoreLivonia/

His discoveries were remarkable and they soon led to the development of the Quantitative Electroencephalogram better known as Qeeg. Neurocore uses this kind of technology to monitor the brainwaves of their patients in an attempt to discern the inherent causes of depression. Unfortunately, Berger struggled with his own demons throughout his entire life and this led to him offing himself at the ripe old age of 78. Nowadays, Neurocore uses EEG and QEEG technology to study the effects of Neurofeedback on patients with depression and they seem to be having a bit of success with it thus far. Out of the 292 patients they’ve treated, over three-quarters of them have noted a significant reduction in their symptoms while over half found they no longer met the requirements of someone with depression. Follow Neurocore on Twitter.

Gary